Literature DB >> 7833947

Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.

P de Knijff1, A M van den Maagdenberg, R R Frants, L M Havekes.   

Abstract

Apolipoprotein E (apoE) is one of the major protein constituents of chylomicron and very-low-density lipoprotein (VLDL) remnants and plays a central role as a ligand in the receptor-mediated uptake of these particles by the liver. Including the most common variant, apoE3, 30 apoE variants have been characterized. At present, 14 apoE variants have been found to be associated with familial dysbetalipoproteinemia, a genetic lipid disorder characterized by elevated plasma cholesterol and triglyceride levels and an increased risk for atherosclerosis. Seven apoE variants were found to be associated with other forms of hyperlipoproteinemia. This report presents an overview of all currently known apoE variants and their effects on lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833947     DOI: 10.1002/humu.1380040303

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Authors:  Yoshiro Miyahara; Shinsuke Nishimura; Maho Watanabe; Kenji Ito; Hitoshi Nakashima; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

3.  Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.

Authors:  Marguerite R Irvin; Edmond K Kabagambe; Hemant K Tiwari; Laurence D Parnell; Robert J Straka; Michael Tsai; Jose M Ordovas; Donna K Arnett
Journal:  Circ Cardiovasc Genet       Date:  2010-08-21

4.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

5.  Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.

Authors:  Santanu Biswas; Pradip K Ghoshal; Bhubaneswar Halder; Kajal Ganguly; Arup DasBiswas; Nripendranath Mandal
Journal:  Indian Heart J       Date:  2013-10-30

6.  Genes and outcome after aneurysmal subarachnoid haemorrhage.

Authors:  Y M Ruigrok; A J C Slooter; A Bardoel; C J M Frijns; G J E Rinkel; C Wijmenga
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

7.  Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.

Authors:  Angel C Y Mak; Clive R Pullinger; Ling Fung Tang; Jinny S Wong; Rahul C Deo; Jean-Marc Schwarz; Alejandro Gugliucci; Irina Movsesyan; Brian Y Ishida; Catherine Chu; Annie Poon; Phillip Kim; Eveline O Stock; Ernst J Schaefer; Bela F Asztalos; Joseph M Castellano; Tony Wyss-Coray; Jacque L Duncan; Bruce L Miller; John P Kane; Pui-Yan Kwok; Mary J Malloy
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

8.  An analytical framework in the general coalescent tree setting for analyzing polymorphisms created by two mutations.

Authors:  Ori Sargsyan
Journal:  J Math Biol       Date:  2014-04-24       Impact factor: 2.259

9.  Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition.

Authors:  Eric H Chang; Attilio Rigotti; Patricio T Huerta
Journal:  Neurobiol Aging       Date:  2007-08-23       Impact factor: 4.673

10.  APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR-RFLP When The Christchurch Variant Is Also Present.

Authors:  Beatriz Candás-Estébanez; Ariadna Padró-Miquel; Cristina Ruiz-Iruela; Emili Corbella-Inglés; Xavier Pintó-Sala; Pedro Alía-Ramos
Journal:  J Clin Lab Anal       Date:  2016-08-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.